Singapore markets closed

Cyclerion Therapeutics, Inc. (CYCN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.9300-0.2100 (-6.69%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-5,263
-5,263
-44,078
-51,647
-77,802
Depreciation & amortisation
0
0
65
472
2,297
Stock-based compensation
1,067
1,067
6,252
9,611
14,992
Change in working capital
-4,601
-4,601
-2,850
1,408
-7,592
Accounts receivable
96
96
4
27
1,346
Accounts payable
-1,772
-1,772
1,142
393
-1,096
Other working capital
-21,245
-21,245
-40,611
-36,524
-74,014
Other non-cash items
-
-
-
881
-1,669
Net cash provided by operating activities
-21,245
-21,245
-40,611
-36,517
-72,490
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-7
-1,524
Net cash used for investing activities
10,402
10,402
0
1,457
18
Cash flows from financing activities
Common stock issued
-
-
0
30,503
24,250
Net cash used provided by (used for) financing activities
5,024
5,024
29
30,785
28,090
Net change in cash
-5,811
-5,811
-40,579
-4,271
-44,389
Cash at beginning of period
13,382
13,382
53,961
58,232
102,621
Cash at end of period
7,571
7,571
13,382
53,961
58,232
Free cash flow
Operating cash flow
-21,245
-21,245
-40,611
-36,517
-72,490
Capital expenditure
-
-
-
-7
-1,524
Free cash flow
-21,245
-21,245
-40,611
-36,524
-74,014